Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Aurobindo Pharma: Strong Dose of Growth Opportunities
Aurobindo Pharma has developed multiple growth opportunities which should play out both in the long term and short term. As the company has commercialised most ventures, its risk reward is getting more favourable and may offer value for investors…
We are a family, and it's really sad' - Nil Gimeno delivers a first win at Le Tour de Langkawi but it could well be Kern Pharma's last
A first win always means a lot, though somehow this one seems like it may mean that bit more, as when Nil Gimeno took his victory on stage 7 of Le Tour de Langkawi it was not just a beginning, but also potentially an end. It was announced earlier…
Avalyn Pharma (NASDAQ:AVLN) Upgraded at Raymond James Financial
Avalyn Pharma (NASDAQ:AVLN - Get Free Report) was upgraded by equities researchers at Raymond James Financial to a 'moderate buy' rating in a research report issued on Friday, Zacks reports. Other research analysts also recently issued research…
Spyglass Pharma (NASDAQ:SGP) Stock Moved Down to Sell by Wall Street Zen
Spyglass Pharma (NASDAQ:SGP - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a 'hold' rating to a 'sell' rating in a note issued to investors on Saturday, Wall Street Zen reports. SGP has been the topic of a number…
Alaska Air In Holding Pattern For Now, Fuel Cost Dominating The Risk Story (NYSE:ALK)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Identify a mentor
I have completed my UG degree and have a strong desire to clear the TNPSC exam, but feel lazy and demotivated. How can I build a consistent study habit? Nithiyasri Are you sure you are not overwhelmed by the massive syllabus? First, confirm that…
Nil Gimeno snares first professional win at stage 7 of Le Tour de Langkawi to Batu Pahat
Nil Gimeno (Equipo Kern Pharma) took his first professional victory on stage 7 of Le Tour de Langkawi to Batu Pahat, as the break of four prevailed despite a charged pursuit by the sprinters teams. Gimeno, who was a frustrating fourth on stage 4…
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
The VanEck Pharmaceutical ETF (PPH -0.07%) provides a lower-cost entry and higher yield than the Invesco Pharmaceuticals ETF (PJP -0.30%), which has shown stronger 1-year returns and more concentrated top holdings. These ETFs target the…
Russia to take 70,000 Indian skilled workers this year, Jaishankar tells parliamentary panel
External Affairs Minister S Jaishankar on Saturday briefed a parliamentary consultative committee on India's “multifaceted” engagement with Russia, highlighting shared ambitions to expand bilateral trade, investment, and energy…
Astrazeneca (NYSE:AZN) Upgraded to Buy at Wall Street Zen
Astrazeneca (NYSE:AZN - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'hold' rating to a 'buy' rating in a research note issued on Saturday, Wall Street Zen reports. The Phase 3 Failure That Sent Biotech Winners…
Mutual Funds returns
EQUITY - LARGE & MID CAP FUNDS Bandhan Large & Mid Cap Fund HYBRID - AGGRESSIVE HYBRID FUNDS BOI AXA Mid & Small Cap Eq&Debt EQUITY - SMALL CAP FUNDS Bank of India Small Cap Fund HYBRID - BALANCED ADVANTAGE FUNDS Baroda BNP Paribas Balanced…
Roche (OTCMKTS:RHHBY) Shares Cross Below 50 Day Moving Average - Here's What Happened
Roche Holding AG (OTCMKTS:RHHBY - Get Free Report)'s stock price crossed below its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $55.11 and traded as low as $51.83. Roche shares last traded at $52.25, with…
Vertex Pharmaceuticals (NASDAQ:VRTX) Share Price Crosses Above Two Hundred Day Moving Average - What's Next?
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) shares passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $477.12 and traded as high as $509.50. Vertex Pharmaceuticals…
NewAmsterdam Pharma (NASDAQ:NAMS) Insider Johannes Jacob Piete Kastelein Sells 50,246 Shares of Stock
Insider Johannes Kastelein sold 50,246 NewAmsterdam Pharma shares at an average price of $25.03, generating approximately $1.26 million. His remaining ownership fell by 42.03% to 69,302 shares; he also sold 125,000 shares in August. NewAmsterdam…
Receive a Daily briefing on Pharma Industry News
Get Started